These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21532147)

  • 1. Inhibition of reactive oxygen species/extracellular signal-regulated kinases pathway by pioglitazone attenuates advanced glycation end products-induced proliferation of vascular smooth muscle cells in rats.
    Yuan X; Zhang Z; Gong K; Zhao P; Qin J; Liu N
    Biol Pharm Bull; 2011; 34(5):618-23. PubMed ID: 21532147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone suppresses advanced glycation end product-induced expression of plasminogen activator inhibitor-1 in vascular smooth muscle cells.
    Yuan X; Liu N
    J Genet Genomics; 2011 May; 38(5):193-200. PubMed ID: 21621740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of peroxisome proliferators activated receptor gamma in mediating proliferation of rat vascular smooth muscle cells induced by advanced glycation end products].
    Yuan XC; Liu NF; Yan JC; Zhang X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Oct; 33(10):940-4. PubMed ID: 16266488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymoquinone Inhibits Angiotensin II-Induced Proliferation and Migration of Vascular Smooth Muscle Cells Through the AMPK/PPARγ/PGC-1α Pathway.
    Pei X; Li X; Chen H; Han Y; Fan Y
    DNA Cell Biol; 2016 Aug; 35(8):426-33. PubMed ID: 27064837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.
    Osman I; Segar L
    Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
    Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
    Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoproterenol inhibits angiotensin II-stimulated proliferation and reactive oxygen species production in vascular smooth muscle cells through heme oxygenase-1.
    Kim JE; Kang YJ; Lee KY; Choi HC
    Biol Pharm Bull; 2009 Jun; 32(6):1047-52. PubMed ID: 19483313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen-rich saline attenuates vascular smooth muscle cell proliferation and neointimal hyperplasia by inhibiting reactive oxygen species production and inactivating the Ras-ERK1/2-MEK1/2 and Akt pathways.
    Chen Y; Jiang J; Miao H; Chen X; Sun X; Li Y
    Int J Mol Med; 2013 Mar; 31(3):597-606. PubMed ID: 23340693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon regulatory factor-1 together with reactive oxygen species promotes the acceleration of cell cycle progression by up-regulating the cyclin E and CDK2 genes during high glucose-induced proliferation of vascular smooth muscle cells.
    Zhang X; Liu L; Chen C; Chi YL; Yang XQ; Xu Y; Li XT; Guo SL; Xiong SH; Shen MR; Sun Y; Zhang CS; Hu KM
    Cardiovasc Diabetol; 2013 Oct; 12():147. PubMed ID: 24119616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress.
    Martín A; Pérez-Girón JV; Hernanz R; Palacios R; Briones AM; Fortuño A; Zalba G; Salaices M; Alonso MJ
    J Hypertens; 2012 Feb; 30(2):315-26. PubMed ID: 22179086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of cyclooxygenase-2 by motorcycle exhaust particulate-induced reactive oxygen species enhances rat vascular smooth muscle cell proliferation.
    Tzeng HP; Yang RS; Ueng TH; Liu SH
    Chem Res Toxicol; 2007 Aug; 20(8):1170-6. PubMed ID: 17645304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidylcholine activates extracellular signal-regulated kinases 1/2 through reactive oxygen species in rat vascular smooth muscle cells.
    Yamakawa T; Tanaka S; Yamakawa Y; Kamei J; Numaguchi K; Motley ED; Inagami T; Eguchi S
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):752-8. PubMed ID: 12006386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling.
    Wu JR; Liou SF; Lin SW; Chai CY; Dai ZK; Liang JC; Chen IJ; Yeh JL
    Pharmacol Res; 2009 Jan; 59(1):48-56. PubMed ID: 18973813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emodin Inhibits Homocysteine-Induced C-Reactive Protein Generation in Vascular Smooth Muscle Cells by Regulating PPARγ Expression and ROS-ERK1/2/p38 Signal Pathway.
    Pang X; Liu J; Li Y; Zhao J; Zhang X
    PLoS One; 2015; 10(7):e0131295. PubMed ID: 26131983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells.
    Di BB; Li HW; Li WP; Shen XH; Sun ZJ; Wu X
    Mol Med Rep; 2015 Apr; 11(4):2601-7. PubMed ID: 25523934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through AMP-activated protein kinase signaling pathway.
    Sung JY; Choi HC
    Vascul Pharmacol; 2012; 56(1-2):1-8. PubMed ID: 21708289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paeoniflorin blocks the proliferation of vascular smooth muscle cells induced by platelet‑derived growth factor‑BB through ROS mediated ERK1/2 and p38 signaling pathways.
    Fan X; Wu J; Yang H; Yan L; Wang S
    Mol Med Rep; 2018 Jan; 17(1):1676-1682. PubMed ID: 29257209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway.
    Kim JS; Kim IK; Lee SY; Song BW; Cha MJ; Song H; Choi E; Lim S; Ham O; Jang Y; Hwang KC
    Cell Biol Int; 2012 Mar; 36(3):305-10. PubMed ID: 22050182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling.
    Gao H; Li H; Li W; Shen X; Di B
    Med Sci Monit; 2017 Dec; 23():6121-6131. PubMed ID: 29278639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species.
    Meng D; Shi X; Jiang BH; Fang J
    Free Radic Biol Med; 2007 Jun; 42(11):1651-60. PubMed ID: 17462533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.